Nurse Practitioner, Primary Care · New York, NY
NPI
1750915344
Since 2020
Specialty
Nurse Practitioner, Primary Care
Code 363LP2300X
Group practices
4
Medicare group memberships
Hospitals
1
Hospital affiliations
1305 York Avenue 2nd Floor
New York, NY, 10021
Phone (646) 962-9800
Groups this clinician bills Medicare through
Medicare paid, 2024
$7,772
147 services
Medicare patients, 2024
113
Average age 75
Drug cost, 2024
$1.4M
720 prescriptions
Company payments, 2025
$344
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Stacyann S Smith was code 99307 (snf e&m), 66 times for 55 patients. In total Stacyann S Smith billed 147 services in 10 codes, and Medicare paid $7,772.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-04-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99307 SNF E&M | Facility | 66 | 55 | $30.17 | $1,991 |
| 99214 Office E&M - Established | Office | 33 | 27 | $91.61 | $3,023 |
| 99309 SNF E&M | Facility | 15 | 15 | $81.75 | $1,226 |
By year: 2022 $9,281 for 172 services; 2023 $25K for 1,233 services; 2024 $7,772 for 147 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 27 | 27 | $75.00 | $2,025 |
| U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within | 27 | 27 | $25.00 | $675 |
Medicare prescription drug claims, 2024
In 2024, the drug Stacyann S Smith prescribed most often to Medicare patients was Baclofen, with 64 prescriptions and refills. In total Stacyann S Smith wrote 720 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Baclofen Generic | 64 | 98 | 20 | $1,546 |
| Dalfampridine Er Dalfampridine | 60 | 76 | 14 | $27K |
| Gabapentin Generic | 48 | 84 | 18 | $1,205 |
| Ampyra Dalfampridine | 39 | 47 | Under 11 | $198K |
| Copaxone Glatiramer Acetate | 28 | 28 | Under 11 | $165K |
| Duloxetine Hcl Generic | 27 | 37 | Under 11 | $488 |
| Avonex Pen (4 Pack) Interferon Beta-1a | 27 | 27 | Under 11 | $236K |
| Teriflunomide Generic | 26 | 26 | Under 11 | $17K |
| Fingolimod Fingolimod Hcl | 23 | 23 | Under 11 | $135K |
| Dimethyl Fumarate Generic | 19 | 23 | Under 11 | $63K |
| Modafinil Generic | 17 | 19 | Under 11 | $960 |
| Tizanidine Hcl Generic | 16 | 21 | Under 11 | $414 |
| Atorvastatin Calcium Generic | 14 | 16 | Under 11 | $336 |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 13 | 13 | Under 11 | $345 |
| Amitriptyline Hcl Generic | 12 | 12 | Under 11 | $114 |
Brand drugs: 162 claims; generic drugs: 558 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Stacyann S Smith $344 ($344 in general payments such as food, travel and fees) from 2 companies. The largest payer was Novo Nordisk Inc with $248.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.